Entacapone used in parkinsonism is:
**Core Concept**
Entacapone is a catechol-O-methyltransferase (COMT) inhibitor used in the management of Parkinson's disease. It works by preventing the breakdown of levodopa, thereby increasing its availability in the brain and enhancing its therapeutic effects.
**Why the Correct Answer is Right**
Entacapone specifically inhibits the enzyme catechol-O-methyltransferase (COMT), which is responsible for the peripheral breakdown of levodopa. By inhibiting COMT, entacapone allows more levodopa to cross the blood-brain barrier and reach the striatum, where it is converted to dopamine, thereby alleviating Parkinsonian symptoms. This mechanism of action is particularly useful in combination with levodopa/carbidopa, as it helps to prolong the duration of levodopa's action and reduce the frequency of dosing.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of entacapone. Entacapone is not a dopamine agonist, and its primary role is not to stimulate dopamine receptors.
**Option B:** This option is incorrect because it is not a well-known property of entacapone. Entacapone is not primarily used as an anticholinergic agent, and its use in Parkinson's disease is not related to its anticholinergic effects.
**Option C:** This option is incorrect because it does not accurately describe the primary mechanism of action of entacapone. Entacapone is not a monoamine oxidase B (MAO-B) inhibitor, and its primary role is not to inhibit the breakdown of dopamine by MAO-B.
**Clinical Pearl / High-Yield Fact**
When using entacapone in combination with levodopa/carbidopa, it is essential to monitor patients for potential side effects such as diarrhea, hypertension, and abnormal liver function tests. Additionally, patients should be advised to avoid taking other medications that may interact with entacapone, such as certain antidepressants and antihypertensives.
**Correct Answer: C. Entacapone is a COMT inhibitor used in the management of Parkinson's disease.**